News

FDA approves Zykadia for late-stage lung cancer

The FDA granted accelerated approval to Zykadia (ceritinib) for patients with a certain type of late-stage (metastatic) non-small cell lung cancer (NSCLC).

2nd May 2014

For more information or an estimate, contact us »

Who we help: